Search Within

Shanu Modi

  1. "Elsevier Inc."
Formats
  1. Journal Article (9)
  2. Meeting Abstract (8)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Breast Medicine Service (19)
  2. Department of Medicine (19)
  3. Solid Tumor Oncology Division (19)
  4. Biostatistics Service (9)
  5. Epidemiology and Biostatistics (9)
  6. Survivorship Research (9)

More Groups

People
  1. Andrew Seidman (7)
  2. Clifford Hudis (7)
  3. Gabriella D'Andrea-Carlino (5)
  4. Larry Norton (5)
  5. Sujata Patil (5)
  6. Chau Dang (4)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (1)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Clinical Breast Cancer (8)
  2. Breast (2)
  3. Cancer Treatment Reviews (2)
  4. European Journal of Cancer (2)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. Advances in Pharmacology (1)

More Publications

Publishers
  1. Elsevier Inc. (19)

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Local therapy for isolated central nervous system progression among patients receiving antibody-drug conjugate therapy
    Research Letter

    Lebow, E. S.; Eichholz, J.; Zhang, Z.; Toumbacaris, N.; Imber, B.; Chen, L.; LaPlant, Q.; Yamada, J.; Pike, L. R. G.; Modi, S.; more...
    Advances in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • A phase 3, open-label trial of neoadjuvant trastuzumab deruxtecan (T-DXd) monotherapy or T-DXd followed by THP vs ddAC-THP in high-risk HER2-positive early-stage breast cancer (DESTINY-Breast11)
    Meeting Abstract

    Harbeck, N.; Boileau, J. F.; Modi, S.; Kelly, C.; Ohno, S.; Wu, J.; Konpa, A.; Herbolsheimer, P.; Safdar, S.; Zhang, Y.; more...
    Breast (2023)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Beyond HER2: Targeting the ErbB receptor family in breast cancer
    Review

    Drago, J. Z.; Ferraro, E.; Abuhadra, N.; Modi, S.
    Cancer Treatment Reviews (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Updated results of phase 1 study of DS-8201a in HER2-expressing or -mutated advanced non-small-cell lung cancer
    Meeting Abstract

    Tsurutani, J.; Park, H.; Doi, T.; Modi, S.; Takahashi, S.; Nakagawa, K.; Krop, I.; Waqar, S.; Yoh, K.; Li, B.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel and dasatinib in metastatic breast cancer
    Journal Article

    Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Triplet combination of endocrine therapy with CDK 4/6 inhibitor, ribociclib, and MTOR inhibitor, everolimus in HR+, HER2-ABC: Results from the dose-expansion cohort
    Meeting Abstract

    Bardia, A.; CorteĢs, J.; Modi, S.; Oliveira, M.; Campone, M.; Ma, B.; Dirix, L.; Weise, A.; Kittaneh, M.; Hewes, B.; more...
    Breast (2017)

    Fulltext@MSK | Save
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Iyengar, N.; Morris, P. G.; Corben, A. D.; Patil, S.; Akram, M.; Towers, R.; Sakr, R. A.; King, T. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer
    Journal Article

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save